Deutsch English Français

Contact

EP1080105

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1080105

EP1080105 - PHENYLALANINE DERIVATIVES HAVING VLA-4 ANTAGONISTIC ACTIVITY [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 04.03.2005 Database last updated on 12.11.2024
Most recent event Tooltip	04.03.2005	Application deemed to be withdrawn	published on 20.04.2005 [2005/16]
Applicant(s)	For all designated states CELLTECH THERAPEUTICS LIMITED 208 Bath Road Slough Berkshire SL1 3WE / GB
	[N/P]
Former [2001/10]	For all designated states CELLTECH THERAPEUTICS LIMITED 216 Bath Road Slough, Berkshire SL1 4EN / GB
Inventor(s)	01 / HEAD, John, Clifford 4 Dorchester Close Maidenhead Berkshire SL6 6RX / GB
	02 / ARCHIBALD, Sarah Catherine, 5 College Glen Maidenhead Berkshire SL6 6BL / GB
	03 / WARRELLOW, Graham John, 4 Wieland Road Oakside Northwood Middlesex HA6 3QU / GB
	04 / PORTER, John Robert, 5 Farm Place Henton Chinnor Oxfordshire 0X9 4AD / GB
	[2001/10]
Representative(s)	Mercer, Christopher Paul, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
	[N/P]
Former [2001/10]	Mercer, Christopher Paul, et al Carpmaels & Ransford 43, Bloomsbury Square London WC1A 2RA / GB
Application number, filing date	99922380.3	21.05.1999
	[2001/10]
	WO1999GB01615
Priority number, date	GB19980011159	22.05.1998 Original published format: GB 9811159
	[2001/10]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9961465
	Date:	02.12.1999
	Language:	EN
	[1999/48]
	Type:	A1 Application with search report
	No.:	EP1080105
	Date:	07.03.2001
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 02.12.1999 takes the place of the publication of the European patent application.
	[2001/10]
Search report(s)	International search report - published on:	EP	02.12.1999
Classification	IPC:	C07K5/078, C07D213/82, A61K38/05, A61K31/425	[2001/10]
	CPC:	C07D213/82 (EP,US); A61P29/00 (EP); C07K5/06139 (EP,US); A61K38/00 (EP,US)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/10]
Title	German:	PHENYLALANINEDERIVATE MIT VLA-4 ANTAGONISTISCHER AKTIVITÄT	[2001/10]
	English:	PHENYLALANINE DERIVATIVES HAVING VLA-4 ANTAGONISTIC ACTIVITY	[2001/10]
	French:	DERIVES PHENILALANINE COMPORTANT UNE ACTIVITE ANTAGONISTE DU VLA-4	[2001/10]
Entry into regional phase	10.11.2000	National basic fee paid
	10.11.2000	Designation fee(s) paid
	10.11.2000	Examination fee paid
Examination procedure	02.11.1999	Request for preliminary examination filed International Preliminary Examining Authority: EP
	10.11.2000	Examination requested [2001/10]
	28.07.2003	Despatch of a communication from the examining division (Time limit: M04)
	01.12.2003	Reply to a communication from the examining division
	29.03.2004	Communication of intention to grant the patent
	09.10.2004	Application deemed to be withdrawn, date of legal effect [2005/16]
	15.11.2004	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2005/16]
Fees paid	Renewal fee
	10.11.2000	Renewal fee patent year 03
	14.05.2002	Renewal fee patent year 04
	13.05.2003	Renewal fee patent year 05
	13.05.2004	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[X]EP0842945 (HOECHST AG [DE]) [X] 1,2,4,13 * the whole document *;
		[X]EP0842943 (HOECHST AG [DE]) [X] 1-4,13 * the whole document *;
		[PX]WO9853814 (MERCK & CO INC [US], et al) [PX] 1-4,9-11,13 * the whole document *;
		[PX]WO9858902 (TANABE SEIYAKU CO [JP], et al) [PX] 1-9,11,13 * See especially examples 45-47,60,61,66,67,70; Tab 6:R.ex 26; Tab. 8: R.ex. 41,42 *;
		[PX]WO9906434 (ATHENA NEUROSCIENCES INC [US], et al) [PX] 1-11,13 * See esp.p. 14, line 41 to page 15, l.8; p.16, l4-7; examples 32-37,51,52; claims 1-26 *;
		[PX]WO9906431 (ATHENA NEUROSCIENCES INC [US], et al) [PX] 1-5,9-11,13 * See esp.examples 109,113 *;
		[PX]WO9906436 (ATHENA NEUROSCIENCES INC [US], et al) [PX] 1-4,9-11,13 * the whole document *;
		[PX]WO9910312 (HOFFMANN LA ROCHE [CH]) [PX] 1-11,13 * See especially claims 1,2,4-34,36-43 *;
		[E]WO9935163 (CELLTECH THERAPEUTICS LTD [GB], et al) [E] 1-4,9-11,13* See especially example 38 *;
		[X] - FU H ET AL, "Preliminary study on synthesis and antitumor activity in vitro of derivatives of timonacic", CHEMICAL ABSTRACTS + INDEXES, (19880425), vol. 108, no. 17, ISSN 0009-2258, XP002114106 [X] 1-4,9-11,13 * abstract no. 150358; see abstract *
		[X] - "N-[(4-Thiazolidinyl)carbonyl] amino acid derivatives", CHEMICAL ABSTRACTS + INDEXES, (19811109), vol. 95, no. 19, ISSN 0009-2258, XP002114107 [X] 1-4,9-11,13 * abstract no.169173; see abstract *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p